Partha Roy

Dr. Partha Roy


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
RVRitu Varshney
Ritu Varshney
SGSumeet Gupta
Sumeet Gupta
PRPartha Roy
Partha Roy

1 July 2018 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
RVRitu Varshney
Ritu Varshney
RVRajat Varshney
Rajat Varshney
RMRutusmita Mishra
Rutusmita Mishra
SGSumeet Gupta
Sumeet Gupta
DSDebabrata Sircar
Debabrata Sircar
PRPartha Roy
Partha Roy

1 November 2014 in Reproductive Toxicology
Verified
Journal Article
Closed access
NKNarender Kumar
Narender Kumar
SSShruti Sharan
Shruti Sharan
SSSwati Srivastava
Swati Srivastava
PRPartha Roy
Partha Roy

14 March 2022 in Cells
Verified
Journal Article
Open access
PDF file
SSSarama Saha
Sarama Saha
PSPraveen Kumar Singh
Praveen Kumar Singh
PRPartha Roy
Partha Roy
Sham KakarSham Kakar
Sham Kakar
Tumor-derived cachectic factors such as proinflammatory cytokines and neuromodulators not only affect skeletal muscle but also affect other organs, including the heart, in the form of cardiac muscle atrophy, fibrosis, and eventual cardiac dysfunction, resulting in poor quality of life and reduced survival. This article reviews the holistic approaches of existing diagnostic, pathophysiological, and multimodal therapeutic interventions targeting the molecular mechanisms that are responsible for cancer-induced cardiac cachexia. The major drivers of cardiac muscle wasting in cancer patients are autophagy activation by the cytokine-NFkB, TGF β-SMAD3, and angiotensin II-SOCE-STIM-Ca2+ pathways. A lack of diagnostic markers and standard treatment protocols hinder the early diagnosis of cardiac dysfunction and the initiation of preventive measures. However, some novel therapeutic strategies, including the use of Withaferin A, have shown promising results in experimental models, but Withaferin A’s effectiveness in human remains to be verified. The combined efforts of cardiologists and oncologists would help to identify cost effective and feasible solutions to restore cardiac function and to increase the survival potential of cancer patients.

1 May 2015 in General and Comparative Endocrinology
Verified
Journal Article
Closed access
NKNarender Kumar
Narender Kumar
SSSwati Srivastava
Swati Srivastava
PRPartha Roy
Partha Roy

1 March 2016 in Life Sciences
Verified
Journal Article
Closed access
NKNarender Kumar
Narender Kumar
SSSwati Srivastava
Swati Srivastava
MBMalgorzata Burek
Malgorzata Burek
CFCarola Y. Förster
Carola Y. Förster
PRPartha Roy
Partha Roy